₨ 450
Boschempa 25mg Tablet contains Empagliflozin, a medication used in the management of type 2 diabetes mellitus. Empagliflozin belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. It works by inhibiting SGLT2 in the kidneys, thereby reducing the reabsorption of glucose and increasing urinary glucose excretion, ultimately leading to lower blood glucose levels.
Boschempa 25mg Tablet is prescribed to improve glycemic control in adults with type 2 diabetes mellitus. It is typically used in combination with diet and exercise to help lower blood sugar levels. By promoting the excretion of glucose in the urine, empagliflozin helps reduce hyperglycemia and may also lead to modest weight loss and improvements in blood pressure.
Common side effects of Boschempa 25mg Tablet may include urinary tract infections, genital yeast infections, increased urination, thirst, and dehydration. Less common but more severe side effects may include hypoglycemia (low blood sugar), ketoacidosis (a serious complication of diabetes), and allergic reactions. It is essential to report any persistent or bothersome side effects to your healthcare provider promptly.
Before taking Boschempa 25mg Tablet, inform your healthcare provider if you have any kidney problems, liver disease, or a history of urinary tract infections. Use caution when using empagliflozin in elderly patients or those with heart failure, as they may be at increased risk of dehydration and kidney problems. Regular monitoring of kidney function and electrolyte levels is recommended during treatment with Boschempa 25mg Tablet.
Boschempa 25mg Tablet is contraindicated in patients with a known hypersensitivity to empagliflozin or any other components of the formulation. It should not be used in patients with type 1 diabetes mellitus or diabetic ketoacidosis. Pregnant or breastfeeding women should consult their healthcare provider before using Boschempa 25mg Tablet.
In summary, Boschempa 25mg Tablet containing empagliflozin is an effective medication for the management of type 2 diabetes mellitus. However, it should be used cautiously, considering potential side effects and contraindications, and under the guidance of a healthcare professional.
This information is for general awareness only. It does not replace advice from your doctor or pharmacist. Always read the leaflet and follow the directions you were given.
These medicines contain the same salt as Boschempa 25mg Tablet (Empagliflozin 25mg), so they are common substitutes. Compare their prices, and change brands only after checking with your doctor or pharmacist.
| Medicine | Manufacturer | Pack | Price |
|---|---|---|---|
| Voreta 25mg Tablet | Scotman Pharmaceuticals | 10 tablets | Rs 340 |
| Truglif 25mg Tablet | ALI Gohar Pharmaceuticals | 14 tablets | Rs 460 |
| Gempaz 25mg Tablet | LCI Pharmaceuticals | 14 tablets | Rs 470.59 |
| Truglif 25 mg Tablet | AGP Pharmacuticals | 14s | Rs 474.77 |
| Empagli 25 mg Tablet | High Q International | 14 tablets | Rs 540 |
| Sciampa 25mg Tablet | Scilife Pharma | 14 tablets | Rs 590 |
| Empaxo 25mg Tablet | Pinnacle Biotech | 14 tablets | Rs 590 |
| Glempa 25mg Tablet | Nabiqasim Industries | 14 tablets | Rs 600 |
| Medicine | Manufacturer | Strength | Price |
|---|---|---|---|
| Voreta 10mg Tablet | Scotman Pharmaceuticals | 10mg | Rs 240 |
| Jemvesta 10mg Tablet | Wilshire Laboratories | 10mg | Rs 280 |
| Emglif 10mg Tablet | Genix Pharma | 10mg | Rs 285 |
| Boschempa 10mg Tablet | Bosch Pharmaceuticals | 10mg | Rs 300 |
See all brands and prices on our Empagliflozin page.
You must be logged in to post a review.
No account yet?
Create an Account
Reviews
Clear filtersThere are no reviews yet.